https://corporate.dukehealth.org/node/4106 DURHAM, N.C. – Antibiotics are currently the only treatments available for Lyme disease and other tick-borne illnesses, but researchers at Duke Health are working to expand the medical toolkit by identifying vulnerable areas of disease-causing bacteria that could lead to innovative therapies.
The research project, which recently received a $3.8 million grant from the Steven & Alexandra Cohen Foundation, relies on drug discovery methods that have proven successful in identifying treatments for cancer and viral diseases.
"Our goal is to find alternatives to antibiotics to treat Lyme disease, which is caused by the Borrelia burgdorferi bacterium, and illnesses that arise from the Bartonella pathogen," said Neil Spector < https://medicine.duke.edu/faculty/neil-lee-spector-md>, M.D., the Sandra Coates Associate Professor Breast Cancer Research at Duke Cancer Institute and the study's co-principal investigator.
Posted by Lymetoo (Member # 743) on :
Hope!
Posted by Tincup (Member # 5829) on :
Excellent! Thanks for sharing. I'm sharing your share.